Clinical outcomes of patients with active rheumatoid arthritis with normal acute phase reactant values-Reference-Cited by-同舟云学术

Clinical outcomes of patients with active rheumatoid arthritis with normal acute phase reactant values

Published:2019-01-24 Issue:5 Volume:22 Page:852-859
ISSN:1756-1841
Container-title:International Journal of Rheumatic Diseases
language:en
Short-container-title:Int J Rheum Dis

Author:

Chung Min Kyung¹^ORCID,Park Bohyun²^ORCID,Kim In Je¹^ORCID,Cho Soo‐Kyung³⁴^ORCID,Kim Dam³⁴^ORCID,Sung Yoon‐Kyoung³⁴^ORCID,Choi Chan‐Bum³⁴^ORCID,Choe Jung‐Yoon⁵^ORCID,Chung Won Tae⁶^ORCID,Hong Seung‐Jae⁷^ORCID,Kim Tae‐Hwan⁴^ORCID,Koh Eunmi⁸,Lee Shin‐Seok⁹^ORCID,Yoon Bo Young¹⁰^ORCID,Park Hyesook²^ORCID,Bae Sang‐Cheol³⁴^ORCID,Lee Jisoo¹^ORCID

Affiliation:

1. Division of Rheumatology, Department of Internal Medicine Ewha Womans University College of Medicine Seoul Korea

2. Department of Preventive Medicine Ewha Womans University College of Medicine Seoul Korea

3. Clinical Research Center for Rheumatoid Arthritis (CRCRA) Hanyang University Hospital for Rheumatic Diseases Seoul Korea

4. Department of Rheumatology Hanyang University Hospital for Rheumatic Diseases Seoul Korea

5. Department of RheumatologyCatholic University of Daegu School of Medicine Daegu Korea

6. Department of RheumatologyDong‐A University Hospital Busan Korea

7. Department of RheumatologyKyung Hee University Hospital Seoul Korea

8. Department of RheumatologySamsung Medical Center Sungkyunkwan University School of Medicine Seoul Korea

9. Department of RheumatologyChonnam National University Medical School and Hospital Gwangju Korea

10. Department of RheumatologyInje University Ilsan Paik Hospital Goyang Korea

Funder

Ministry of Health and Welfare

Publisher

Wiley

Subject

Rheumatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/1756-185X.13469

Reference27 articles.

1. Clinical disease activity and acute phase reactant levels are discordant among patients with active rheumatoid arthritis: acute phase reactant levels contribute separately to predicting outcome at one year

2. Predictors of joint damage in patients with early rheumatoid arthritis treated with high-dose methotrexate with or without concomitant infliximab: Results from the ASPIRE trial

3. Individual relationship between progression of radiological damage and the acute phase response in early rheumatoid arthritis. Towards development of a decision support system;Leeuwen MA;J Rheumatol,1997

4. Is it possible to predict radiological damage in early rheumatoid arthritis (RA)? A report on the occurrence, progression, and prognostic factors of radiological erosions over the first 3 years in 866 patients from the Early RA Study (ERAS);Dixey J;J Rheumatol Suppl,2004

5. Prediction of disease progression in early rheumatoid arthritis by ICTP, RF and CRP. A comparative 3-year follow-up study